INMD on Nasdaq

InMode Ltd.

Electromedical and electrotherapeutic apparatus company. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

$370.5MRevenue, fiscal 20252
$93.8MNet income, fiscal 20252

Compare with TransMedics Group, Inc., Axogen, Inc. or Zynex, or pick any stock.

  • TickerINMD on Nasdaq1
  • IndustryElectromedical & Electrotherapeutic Apparatus1
  • HeadquartersL31
  • Incorporated inIsrael3
  • Business addressTavor Building, Sha?Ar Yokneam, Pob 533, Yokneam, L3 20692003
  • Filer categoryLarge accelerated filer3

RF energy depends on the distance between the two electrodes on the probe, with increasing distance resulting in increased depth of penetration.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

78.5%Gross margin2
23.0%Operating margin2
25.3%Net margin2
-6.2%Revenue growth, 20252
13.7%Return on equity2
$84.3MFree cash flow2

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Capital Equipment brought in 78% of the revenue InMode Ltd. broke down this way in fiscal 2025.

  1. Capital Equipment$289.1M278%down 8% from 2024
  2. Consumables And Service Revenues$81.4M222%up 3% from 2024
Products and services by year
Products and services202320242025
Capital Equipment$412.1M$315.5M$289.1M
Consumables And Service Revenues$80.0M$79.3M$81.4M

Regions

United States brought in 54% of the revenue InMode Ltd. broke down this way in fiscal 2025.

  1. United States$198.7M254%down 19% from 2024
  2. Europe$79.0M221%up 25% from 2024
  3. Asia$49.2M213%up 15% from 2024
  4. Other Country$40.2M211%up 1% from 2024
  5. Israel$3.4M21%down 9% from 2024
Regions by year
Regions202320242025
United States$307.8M$244.8M$198.7M
Europe$62.5M$63.4M$79.0M
Asia$47.7M$43.0M$49.2M
Other Country$71.1M$39.9M$40.2M
Israel$2.9M$3.7M$3.4M

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue21¢$79.5M
  • Research and development4¢$13.3M
  • Other costs45¢$167.3M
  • Income tax4¢$16.5M
  • Profit25¢$93.8M

Out of $370.5M in revenue.2

Where each dollar of operating cash went, fiscal 2025

  • Capital spending1¢$972.0K
  • Share buybacks99¢$127.4M

Out of $85.3M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.2

Financial statements

Revenue567892$370.5M in 2025+270% since 2018
0$200.0M$400.0M$600.0M2018: $100.2M$100.2M20182019: $156.4M$156.4M2019+56%2020: $206.1M$206.1M2020+32%2021: $357.6M$357.6M2021+73%2022: $454.3M$454.3M2022+27%2023: $492.0M$492.0M2023+8%2024: $394.8M$394.8M2024−20%2025: $370.5M$370.5M2025−6%
Gross profit567892$291.0M in 2025+242% since 2018
0$200.0M$400.0M$600.0M2018: $85.1M$85.1M20182019: $136.1M$136.1M2019+60%2020: $175.3M$175.3M2020+29%2021: $304.0M$304.0M2021+73%2022: $380.8M$380.8M2022+25%2023: $411.3M$411.3M2023+8%2024: $317.1M$317.1M2024−23%2025: $291.0M$291.0M2025−8%
Operating income567892$85.4M in 2025+264% since 2018
0$50.0M$100.0M$150.0M$200.0M2018: $23.5M$23.5M20182019: $59.6M$59.6M2019+154%2020: $72.8M$72.8M2020+22%2021: $167.5M$167.5M2021+130%2022: $197.9M$197.9M2022+18%2023: $195.7M$195.7M2023−1%2024: $112.5M$112.5M2024−42%2025: $85.4M$85.4M2025−24%
Net income56782$93.8M in 2025+319% since 2018
0$50.0M$100.0M$150.0M$200.0M2018: $22.4M$22.4M20182019: $61.1M$61.1M2019+173%2020: $75.0M$75.0M2020+23%2021: $165.0M$165.0M2021+120%2022: $161.5M$161.5M2022−2%2023: $197.9M$197.9M2023+23%2024: $181.3M$181.3M2024−8%2025: $93.8M$93.8M2025−48%

Every line of the income statement as filed: the last 3 fiscal years, latest first.2

Period ending2025-12-312024-12-312023-12-31
REVENUES$370.5M$394.8M$492.0M
COST OF REVENUES$79.5M$77.8M$80.7M
GROSS PROFIT$291.0M$317.1M$411.3M
Research and development$13.3M$13.1M$13.4M
Sales and marketing$180.6M$181.4M$193.0M
General and administrative$11.7M$10.0M$9.2M
TOTAL OPERATING EXPENSES$205.6M$204.5M$215.7M
OPERATING INCOME$85.4M$112.5M$195.7M
Finance income, net$24.9M$30.9M$21.6M
INCOME BEFORE INCOME TAXES$110.3M$143.5M$217.3M
INCOME TAXES BENEFIT (EXPENSES)-$16.5M$37.8M-$19.3M
NET INCOME$93.8M$181.3M$197.9M
Basic$1.45$2.29$2.37
Diluted$1.43$2.25$2.30
Basic64.6M shares79.3M shares83.5M shares
Diluted65.4M shares80.6M shares86.0M shares

Compare InMode Ltd. with another company

Leadership

Who has led InMode Ltd., and when. Pick a name to see everywhere that person has worked.

Board members and other officers (7)

Timeline

  1. Mar 18, 2026New chief executive Moshe Mizrahy becomes CEO11

Filings

88 filings to the SEC since October 2021: 5 annual reports, 13 insider forms, 11 large holders, 59 other. The latest 20:

  1. Sep 16, 20266-K EDGAR
  2. Aug 11, 20266-K EDGAR
  3. Aug 5, 2026SCHEDULE 13D/A EDGAR
  4. Aug 5, 20264 EDGAR
  5. Aug 5, 20266-K EDGAR
  6. Aug 3, 20266-K EDGAR
  7. Jul 30, 20264 EDGAR
  8. Jul 30, 20264 EDGAR
  9. Jul 30, 20264 EDGAR
  10. Jul 20, 20266-K EDGAR
  11. Jul 13, 20266-K EDGAR
  12. Jul 10, 20266-K EDGAR
  13. Jun 25, 20266-K EDGAR
  14. Jun 24, 2026SCHEDULE 13D/A EDGAR
  15. Jun 24, 20266-K EDGAR
  16. Jun 18, 20266-K EDGAR
  17. May 26, 20263 EDGAR
  18. May 26, 20263 EDGAR
  19. May 20, 20266-K EDGAR
  20. May 6, 20266-K EDGAR

The 88 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Members of Congress who traded it

2 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Feb 24, 2020Tom Rice, HouseSale$1,001 - $15,000+159.7%Report
Feb 24, 2020Tom Rice, HouseSale$1,001 - $15,000+159.7%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).